Xueqin Yang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC (NCT06142058) | Xueqin Yang | 2023-11-13 |
Track Xueqin Yang automatically
Every clearance here is in the API, with alerts when new ones post.